» Articles » PMID: 1457409

Expression of Platelet-derived Endothelial Cell Growth Factor in Escherichia Coli and Confirmation of Its Thymidine Phosphorylase Activity

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1992 Dec 8
PMID 1457409
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-derived endothelial cell growth factor (PD-ECGF) has been expressed in Escherichia coli as a fusion protein with glutathione S-transferase (GST). The fusion protein was purified by one-step affinity chromatography on glutathione-agarose beads, and recombinant PD-ECGF was proteolytically cleaved with thrombin from its GST leader peptide to yield pure protein. Recombinant PD-ECGF stimulated [3H]methylthymidine uptake by endothelial cells in vitro; however, we were unable to detect stimulation of cell proliferation under a wide variety of conditions. We confirm that in accord with the recent report that PD-ECGF and human thymidine phosphorylase are products of the same gene [Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., & Akiyama, S. I. (1992) Nature 356, 668] recombinant PD-ECGF has thymidine phosphorylase activity comparable to that of E. coli thymidine phosphorylase. Further, E. coli thymidine phosphorylase was able to mimic the activity of recombinant PD-ECGF in the [3H]methylthymidine uptake assay, and it appears that recombinant PD-ECGF's effect on the uptake of thymidine by endothelial cells may be due to modulation of cellular thymidine pools. The mechanism by which PD-ECGF stimulates angiogenesis remains to be elucidated.

Citing Articles

Investigation of novel bis-thiadiazole bearing schiff base derivatives as effective inhibitors of thymidine phosphorylase: Synthesis, in vitro bioactivity and molecular docking study.

Hussain R, Rehman W, Khan S, Jaber F, Rahim F, Shah M Saudi Pharm J. 2023; 31(11):101823.

PMID: 37965293 PMC: 10641276. DOI: 10.1016/j.jsps.2023.101823.


Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.

Puthiamadathil J, Weinberg B Cancer Manag Res. 2017; 9:461-469.

PMID: 29056855 PMC: 5635852. DOI: 10.2147/CMAR.S113320.


Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.

Peters G Ther Adv Med Oncol. 2015; 7(6):340-56.

PMID: 26557901 PMC: 4622302. DOI: 10.1177/1758834015603313.


Thymidine Phosphorylase in Cancer; Enemy or Friend?.

Elamin Y, Rafee S, Osman N, O Byrne K, Gately K Cancer Microenviron. 2015; 9(1):33-43.

PMID: 26298314 PMC: 4842186. DOI: 10.1007/s12307-015-0173-y.


Genome-scale identification and characterization of moonlighting proteins.

Khan I, Chen Y, Dong T, Hong X, Takeuchi R, Mori H Biol Direct. 2014; 9:30.

PMID: 25497125 PMC: 4307903. DOI: 10.1186/s13062-014-0030-9.